Medicine, Inc. (NASDAQ:FMI) and Roche (SIX: RO, ROG; OTCQX: RHHBY)
announced today that they will enter into a broad strategic
collaboration to further advance Foundation Medicine’s market-leading
position in molecular information and genomic analysis while providing
Roche a unique opportunity to optimize the identification and
development of novel treatment options for cancer patients.
for Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology investment picks